Moors & Cabot, Inc. Edwards Lifesciences Corp Transaction History

Moors & Cabot, Inc.

$1.96 Billion
Q3 2024

A detailed history of Moors & Cabot, Inc. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Moors & Cabot, Inc. holds 54,437 shares of EW stock, worth $4.07 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

54,437

Previous 54,512 0.14%

Holding current value

$4.07 Million

Previous $5.04 Million 28.66%

% of portfolio

0.18%

Previous 0.27%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$59.7 - $93.78 $4,477 - $7,033	-75 Reduced 0.14%	54,437 $3.59 Million
Q2 2024 Aug 09, 2024	BUY	$84.3 - $94.31 $89,610 - $100,251	1,063 Added 1.99%	54,512 $5.04 Million
Q1 2024 May 08, 2024	BUY	$72.54 - $95.56 $213,993 - $281,902	2,950 Added 5.84%	53,449 $5.11 Million
Q4 2023 Feb 14, 2024	BUY	$61.71 - $77.76 $97,748 - $123,171	1,584 Added 3.24%	50,499 $3.85 Million
Q3 2023 Nov 07, 2023	SELL	$69.28 - $93.38 $48,842 - $65,832	-705 Reduced 1.42%	48,915 $3.39 Million
Q2 2023 Aug 09, 2023	BUY	$81.41 - $94.33 $16,933 - $19,620	208 Added 0.42%	49,620 $4.68 Million
Q1 2023 May 04, 2023	BUY	$74.26 - $84.51 $48,417 - $55,100	652 Added 1.34%	49,412 $4.09 Million
Q4 2022 Feb 09, 2023	BUY	$68.3 - $87.44 $120,959 - $154,856	1,771 Added 3.77%	48,760 $3.64 Million
Q4 2022 Feb 06, 2023	SELL	$68.3 - $87.44 $115,495 - $147,861	-1,691 Reduced 3.47%	46,989 $3.51 Million
Q3 2022 Nov 07, 2022	SELL	$82.37 - $107.29 $129,485 - $168,659	-1,572 Reduced 3.13%	48,680 $4.02 Million
Q2 2022 Aug 08, 2022	SELL	$86.5 - $128.27 $5,363 - $7,952	-62 Reduced 0.12%	50,252 $4.78 Million
Q1 2022 May 13, 2022	SELL	$101.96 - $128.34 $104,509 - $131,548	-1,025 Reduced 2.0%	50,314 $5.92 Million
Q4 2021 Feb 14, 2022	SELL	$106.37 - $130.68 $198,167 - $243,456	-1,863 Reduced 3.5%	51,339 $6.65 Million
Q3 2021 Dec 08, 2021	BUY	$102.91 - $122.75 $5.48 Million - $6.53 Million	53,202 New	53,202 $6.02 Million
Q3 2021 Nov 05, 2021	SELL	$102.91 - $122.75 $5.51 Million - $6.57 Million	-53,524 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$83.84 - $104.76 $36,386 - $45,465	434 Added 0.82%	53,524 $5.54 Million
Q1 2021 May 12, 2021	SELL	$78.68 - $90.67 $130,608 - $150,512	-1,660 Reduced 3.03%	53,090 $4.44 Million
Q4 2020 Feb 11, 2021	SELL	$71.69 - $91.23 $47,817 - $60,850	-667 Reduced 1.2%	54,750 $4.99 Million
Q3 2020 Nov 09, 2020	BUY	$67.19 - $87.44 $12,497 - $16,263	186 Added 0.34%	55,417 $4.42 Million
Q2 2020 Aug 13, 2020	BUY	$57.54 - $76.95 $2.08 Million - $2.79 Million	36,213 Added 190.41%	55,231 $3.81 Million
Q1 2020 May 12, 2020	SELL	$52.41 - $81.0 $75,313 - $116,397	-1,437 Reduced 7.03%	19,018 $3.59 Million
Q4 2019 Jan 28, 2020	SELL	$71.7 - $82.09 $57,718 - $66,082	-805 Reduced 3.79%	20,455 $4.77 Million
Q3 2019 Oct 22, 2019	BUY	$61.55 - $75.43 $44,069 - $54,007	716 Added 3.49%	21,260 $4.67 Million
Q2 2019 Jul 18, 2019	BUY	$55.74 - $64.41 $23,076 - $26,665	414 Added 2.06%	20,544 $3.79 Million
Q1 2019 May 06, 2019	SELL	$47.89 - $64.05 $964,025 - $1.29 Million	-20,130 Reduced 50.0%	20,130 $3.85 Million
Q1 2019 May 01, 2019	BUY	$47.89 - $64.05 $988,976 - $1.32 Million	20,651 Added 105.31%	40,260 $7.7 Million
Q4 2018 Feb 13, 2019	BUY	$46.41 - $56.94 $93,284 - $114,449	2,010 Added 11.42%	19,609 $3.01 Million
Q3 2018 Nov 14, 2018	BUY	$45.7 - $58.03 $70,286 - $89,250	1,538 Added 9.58%	17,599 $3.06 Million
Q2 2018 Aug 14, 2018	BUY	$42.45 - $51.3 $10,315 - $12,465	243 Added 1.54%	16,061 $2.34 Million
Q1 2018 May 18, 2018	SELL	$37.19 - $47.45 $195,359 - $249,254	-5,253 Reduced 24.93%	15,818 $2.21 Million
Q4 2017 Feb 13, 2018	SELL	$33.79 - $39.39 $2,230 - $2,599	-66 Reduced 0.31%	21,071 $2.38 Million
Q3 2017 Nov 16, 2017	SELL	$36.29 - $38.83 $64,051 - $68,534	-1,765 Reduced 7.71%	21,137 $2.31 Million
Q2 2017 Aug 15, 2017	BUY	N/A	22,902	22,902 $2.7 Million

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

457M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $46.3B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Moors & Cabot, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Moors & Cabot, Inc. with notifications on news.

Account